{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:39:05Z","timestamp":1791517145083,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1038\/s41591-022-02113-6","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T12:02:57Z","timestamp":1673265777000},"page":"158-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3382-9769","authenticated-orcid":false,"given":"Erin M.","family":"Parry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8942-9265","authenticated-orcid":false,"given":"Ignaty","family":"Leshchiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7563-580X","authenticated-orcid":false,"given":"Romain","family":"Gui\u00e8ze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Tausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3221-7314","authenticated-orcid":false,"given":"Sameer A.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5772-8743","authenticated-orcid":false,"given":"Camilla","family":"Lemvigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6689-4006","authenticated-orcid":false,"given":"Julien","family":"Bros\u00e9us","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8456-7992","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Hergalant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4167-7221","authenticated-orcid":false,"given":"Conor","family":"Messer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3226-7642","authenticated-orcid":false,"given":"Filippo","family":"Utro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9251-2294","authenticated-orcid":false,"given":"Chaya","family":"Levovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahn","family":"Rhrissorrakrai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rosebrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanye","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0943-1339","authenticated-orcid":false,"given":"Stephanie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Slowik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teddy","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9106-6141","authenticated-orcid":false,"given":"Shuqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6436-6691","authenticated-orcid":false,"given":"Geoff","family":"Fell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1329-5288","authenticated-orcid":false,"given":"Robert","family":"Redd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4962-9956","authenticated-orcid":false,"given":"Binyamin A.","family":"Knisbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2528-1446","authenticated-orcid":false,"given":"Dimitri","family":"Livitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4409-9503","authenticated-orcid":false,"given":"Neil","family":"Ruthen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liudmila","family":"Elagina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7249-2425","authenticated-orcid":false,"given":"Amaro","family":"Taylor-Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1198-4389","authenticated-orcid":false,"given":"Bria","family":"Persaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9300-872X","authenticated-orcid":false,"given":"Aina","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey M.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Purroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle J.","family":"Anandappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1387-4009","authenticated-orcid":false,"given":"Julian","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Z.","family":"Rassenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Kipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7357-270X","authenticated-orcid":false,"given":"William","family":"Wierda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Cymbalista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Feugier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5951-5055","authenticated-orcid":false,"given":"Neil E.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9105-5856","authenticated-orcid":false,"given":"Kenneth J.","family":"Livak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6839-6337","authenticated-orcid":false,"given":"Brian P.","family":"Danysh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chip","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2566-3145","authenticated-orcid":false,"given":"Donna","family":"Neuberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4529-2003","authenticated-orcid":false,"given":"Matthew S.","family":"Davids","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2040-4961","authenticated-orcid":false,"given":"Jennifer R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7872-5074","authenticated-orcid":false,"given":"Laxmi","family":"Parida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6830-9296","authenticated-orcid":false,"given":"Stephan","family":"Stilgenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-0753","authenticated-orcid":false,"given":"Gad","family":"Getz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3348-5054","authenticated-orcid":false,"given":"Catherine J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"2113_CR1","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.jtho.2019.06.002","volume":"14","author":"M Offin","year":"2019","unstructured":"Offin, M. et al. Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes. J. Thorac. Oncol. 14, 1784\u20131793 (2019).","journal-title":"J. Thorac. Oncol."},{"key":"2113_CR2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1200\/JCO.18.01055","volume":"37","author":"AD Volta","year":"2019","unstructured":"Volta, A. D. et al. Transformation of prostate adenocarcinoma into small-cell neuroendocrine cancer under androgen deprivation therapy: much is achieved but more information is needed. J. Clin. Oncol. 37, 350\u2013351 (2019).","journal-title":"J. Clin. Oncol."},{"key":"2113_CR3","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1182\/blood-2013-11-516229","volume":"123","author":"SA Parikh","year":"2014","unstructured":"Parikh, S. A., Kay, N. E. & Shanafelt, T. D. How we treat Richter syndrome. Blood 123, 1647\u20131657 (2014).","journal-title":"Blood"},{"key":"2113_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature15395","volume":"526","author":"DA Landau","year":"2015","unstructured":"Landau, D. A. et al. Mutations driving CLL and their evolution in progression and relapse. Nature 526, 525\u2013530 (2015).","journal-title":"Nature"},{"key":"2113_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature14666","volume":"526","author":"XS Puente","year":"2015","unstructured":"Puente, X. S. et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 526, 519\u2013524 (2015).","journal-title":"Nature"},{"key":"2113_CR6","doi-asserted-by":"crossref","unstructured":"Knisbacher, B. A. et al. Molecular map of chronic lymphocytic leukemia and its impact on outcome. Nat. Genet. 54, 1664\u20131674 (2022).","DOI":"10.1038\/s41588-022-01140-w"},{"key":"2113_CR7","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1182\/blood-2013-03-489518","volume":"122","author":"E Chigrinova","year":"2013","unstructured":"Chigrinova, E. et al. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. Blood 122, 2673\u20132682 (2013).","journal-title":"Blood"},{"key":"2113_CR8","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1084\/jem.20131448","volume":"210","author":"G Fabbri","year":"2013","unstructured":"Fabbri, G. et al. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome. J. Exp. Med. 210, 2273\u20132288 (2013).","journal-title":"J. Exp. Med."},{"key":"2113_CR9","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1182\/blood.2020005650","volume":"137","author":"J Klintman","year":"2021","unstructured":"Klintman, J. et al. Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia. Blood 137, 2800\u20132816 (2021).","journal-title":"Blood"},{"key":"2113_CR10","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1182\/blood-2010-09-302174","volume":"117","author":"D Rossi","year":"2011","unstructured":"Rossi, D. et al. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood 117, 3391\u20133401 (2011).","journal-title":"Blood"},{"key":"2113_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41592-018-0036-9","volume":"15","author":"A Taylor-Weiner","year":"2018","unstructured":"Taylor-Weiner, A. et al. DeTiN: overcoming tumor-in-normal contamination. Nat. Methods 15, 531\u2013534 (2018).","journal-title":"Nat. Methods"},{"key":"2113_CR12","doi-asserted-by":"crossref","unstructured":"Leshchiner, I. et al. Comprehensive analysis of tumour initiation, spatial and temporal progression under multiple lines of treatment. Preprint at bioRxiv 508127 (2018).","DOI":"10.1101\/508127"},{"key":"2113_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214\u2013218 (2013).","journal-title":"Nature"},{"key":"2113_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"2113_CR15","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz, R. et al. Genetics and pathogenesis of diffuse large B-cell lymphoma. N. Engl. J. Med. 378, 1396\u20131407 (2018).","journal-title":"N. Engl. J. Med."},{"key":"2113_CR16","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1182\/blood.2019002067","volume":"134","author":"B Chapuy","year":"2019","unstructured":"Chapuy, B. et al. Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade. Blood 134, 2369\u20132382 (2019).","journal-title":"Blood"},{"key":"2113_CR17","doi-asserted-by":"publisher","first-page":"6117","DOI":"10.1158\/0008-5472.CAN-21-1273","volume":"81","author":"A Biran","year":"2021","unstructured":"Biran, A. et al. Activation of Notch and Myc Signaling via B-cell-restricted depletion of Dnmt3a generates a consistent murine model of chronic lymphocytic leukemia. Cancer Res. 81, 6117\u20136130 (2021).","journal-title":"Cancer Res."},{"key":"2113_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22458-9","volume":"12","author":"VS Mahajan","year":"2021","unstructured":"Mahajan, V. S. et al. B1a and B2 cells are characterized by distinct CpG modification states at DNMT3A-maintained enhancers. Nat. Commun. 12, 2208 (2021).","journal-title":"Nat. Commun."},{"key":"2113_CR19","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy, B. et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat. Med. 24, 679\u2013690 (2018).","journal-title":"Nat. Med."},{"key":"2113_CR20","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","volume":"20","author":"M Challa-Malladi","year":"2011","unstructured":"Challa-Malladi, M. et al. Combined genetic inactivation of beta2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell 20, 728\u2013740 (2011).","journal-title":"Cancer Cell"},{"key":"2113_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01062-w","volume":"8","author":"M Sade-Feldman","year":"2017","unstructured":"Sade-Feldman, M. et al. Resistance to checkpoint blockade therapy through inactivation of antigen presentation. Nat. Commun. 8, 1136 (2017).","journal-title":"Nat. Commun."},{"key":"2113_CR22","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1158\/2159-8290.CD-17-0593","volume":"7","author":"S Gettinger","year":"2017","unstructured":"Gettinger, S. et al. Impaired HLA Class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer. Cancer Disco. 7, 1420\u20131435 (2017).","journal-title":"Cancer Disco."},{"key":"2113_CR23","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1084\/jem.20181726","volume":"216","author":"K Singh","year":"2019","unstructured":"Singh, K. et al. c-MYC regulates mRNA translation efficiency and start-site selection in lymphoma. J. Exp. Med. 216, 1509\u20131524 (2019).","journal-title":"J. Exp. Med."},{"key":"2113_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccell.2018.07.003","volume":"34","author":"SC Lee","year":"2018","unstructured":"Lee, S. C. et al. Synthetic lethal and convergent biological effects of cancer-associated spliceosomal gene mutations. Cancer Cell 34, 225\u2013241 e228 (2018).","journal-title":"Cancer Cell"},{"key":"2113_CR25","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3324\/haematol.2019.217307","volume":"105","author":"J Edelmann","year":"2020","unstructured":"Edelmann, J. et al. Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription. Haematologica 105, 1379\u20131390 (2020).","journal-title":"Haematologica"},{"key":"2113_CR26","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1182\/blood-2017-01-763003","volume":"129","author":"MA Anderson","year":"2017","unstructured":"Anderson, M. A. et al. Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax. Blood 129, 3362\u20133370 (2017).","journal-title":"Blood"},{"key":"2113_CR27","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1002\/cncr.30596","volume":"123","author":"P Jain","year":"2017","unstructured":"Jain, P. et al. Long-term outcomes for patients with chronic lymphocytic leukemia who discontinue ibrutinib. Cancer 123, 2268\u20132273 (2017).","journal-title":"Cancer"},{"key":"2113_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/jamaoncol.2014.218","volume":"1","author":"KJ Maddocks","year":"2015","unstructured":"Maddocks, K. J. et al. Etiology of ibrutinib therapy discontinuation and outcomes in patients with chronic lymphocytic leukemia. JAMA Oncol. 1, 80\u201387 (2015).","journal-title":"JAMA Oncol."},{"key":"2113_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11589","volume":"7","author":"JA Burger","year":"2016","unstructured":"Burger, J. A. et al. Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition. Nat. Commun. 7, 11589 (2016).","journal-title":"Nat. Commun."},{"key":"2113_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ccell.2019.08.005","volume":"36","author":"R Guieze","year":"2019","unstructured":"Guieze, R. et al. Mitochondrial reprogramming underlies resistance to BCL-2 inhibition in lymphoid malignancies. Cancer Cell 36, 369\u2013384 e313 (2019).","journal-title":"Cancer Cell"},{"key":"2113_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9866","volume":"6","author":"S Kasar","year":"2015","unstructured":"Kasar, S. et al. Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution. Nat. Commun. 6, 8866 (2015).","journal-title":"Nat. Commun."},{"key":"2113_CR32","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-019-1252-x","volume":"570","author":"M Gruber","year":"2019","unstructured":"Gruber, M. et al. Growth dynamics in naturally progressing chronic lymphocytic leukaemia. Nature 570, 474\u2013479 (2019).","journal-title":"Nature"},{"key":"2113_CR33","doi-asserted-by":"publisher","first-page":"13033","DOI":"10.1073\/pnas.0801610105","volume":"105","author":"N Zhang","year":"2008","unstructured":"Zhang, N. et al. Overexpression of Separase induces aneuploidy and mammary tumorigenesis. Proc. Natl Acad. Sci. USA 105, 13033\u201313038 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2113_CR34","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396\u20131401 (2014).","journal-title":"Science"},{"key":"2113_CR35","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41587-020-0591-3","volume":"38","author":"V Bergen","year":"2020","unstructured":"Bergen, V., Lange, M., Peidli, S., Wolf, F. A. & Theis, F. J. Generalizing RNA velocity to transient cell states through dynamical modeling. Nat. Biotechnol. 38, 1408\u20131414 (2020).","journal-title":"Nat. Biotechnol."},{"key":"2113_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00965-y","volume":"8","author":"VA Adalsteinsson","year":"2017","unstructured":"Adalsteinsson, V. A. et al. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. Nat. Commun. 8, 1324 (2017).","journal-title":"Nat. Commun."},{"key":"2113_CR37","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/s41591-022-01927-8","volume":"28","author":"F Nadeu","year":"2022","unstructured":"Nadeu, F. et al. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia. Nat. Med. 28, 1662\u20131671 (2022).","journal-title":"Nat. Med."},{"key":"2113_CR38","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1182\/bloodadvances.2017007302","volume":"1","author":"CR Miller","year":"2017","unstructured":"Miller, C. R. et al. Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib. Blood Adv. 1, 1584\u20131588 (2017).","journal-title":"Blood Adv."},{"key":"2113_CR39","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-020-03133-3","volume":"590","author":"RJ Quinton","year":"2021","unstructured":"Quinton, R. J. et al. Whole-genome doubling confers unique genetic vulnerabilities on tumour cells. Nature 590, 492\u2013497 (2021).","journal-title":"Nature"},{"key":"2113_CR40","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/his.13024","volume":"69","author":"EJ Soilleux","year":"2016","unstructured":"Soilleux, E. J. et al. Diagnostic dilemmas of high-grade transformation (Richter\u2019s syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central review. Histopathology 69, 1066\u20131076 (2016).","journal-title":"Histopathology"},{"key":"2113_CR41","doi-asserted-by":"crossref","unstructured":"Favini, C. et al. Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome. Br. J. Haematol. 198, 1016\u20131022 (2022).","DOI":"10.1111\/bjh.18352"},{"key":"2113_CR42","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41591-019-0561-9","volume":"25","author":"AR Parikh","year":"2019","unstructured":"Parikh, A. R. et al. Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers. Nat. Med. 25, 1415\u20131421 (2019).","journal-title":"Nat. Med."},{"key":"2113_CR43","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20, 1297\u20131303 (2010).","journal-title":"Genome Res"},{"key":"2113_CR44","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat. Methods 15, 591\u2013594 (2018).","journal-title":"Nat. Methods"},{"key":"2113_CR45","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1093\/bioinformatics\/btac586","volume":"38","author":"GF Gao","year":"2022","unstructured":"Gao, G. F. et al. Tangent normalization for somatic copy-number inference in cancer genome analysis. Bioinformatics 38, 4677\u20134686 (2022).","journal-title":"Bioinformatics"},{"key":"2113_CR46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"Consortium, I.T.P.-C.A.o.W.G.","year":"2020","unstructured":"Consortium, I.T.P.-C.A.o.W.G. Pan-cancer analysis of whole genomes. Nature 578, 82\u201393 (2020).","journal-title":"Nature"},{"key":"2113_CR47","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/bioinformatics\/btv710","volume":"32","author":"X Chen","year":"2016","unstructured":"Chen, X. et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics 32, 1220\u20131222 (2016).","journal-title":"Bioinformatics"},{"key":"2113_CR48","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1101\/gr.221028.117","volume":"28","author":"JA Wala","year":"2018","unstructured":"Wala, J. A. et al. SvABA: genome-wide detection of structural variants and indels by local assembly. Genome Res 28, 581\u2013591 (2018).","journal-title":"Genome Res"},{"key":"2113_CR49","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/ng.936","volume":"43","author":"AJ Bass","year":"2011","unstructured":"Bass, A. J. et al. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat. Genet. 43, 964\u2013968 (2011).","journal-title":"Nat. Genet."},{"key":"2113_CR50","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1101\/gr.141382.112","volume":"23","author":"Y Drier","year":"2013","unstructured":"Drier, Y. et al. Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. Genome Res 23, 228\u2013235 (2013).","journal-title":"Genome Res"},{"key":"2113_CR51","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","volume":"18","author":"Z Sondka","year":"2018","unstructured":"Sondka, Z. et al. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers. Nat. Rev. Cancer 18, 696\u2013705 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"2113_CR52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"2113_CR53","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/biostatistics\/kxh008","volume":"5","author":"AB Olshen","year":"2004","unstructured":"Olshen, A. B., Venkatraman, E. S., Lucito, R. & Wigler, M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5, 557\u2013572 (2004).","journal-title":"Biostatistics"},{"key":"2113_CR54","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1073\/pnas.0308531101","volume":"101","author":"JP Brunet","year":"2004","unstructured":"Brunet, J. P., Tamayo, P., Golub, T. R. & Mesirov, J. P. Metagenes and molecular pattern discovery using matrix factorization. Proc. Natl Acad. Sci. USA 101, 4164\u20134169 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2113_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"2113_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).","journal-title":"Genome Biol."},{"key":"2113_CR57","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2113_CR58","doi-asserted-by":"publisher","first-page":"lqaa078","DOI":"10.1093\/nargab\/lqaa078","volume":"2","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Parmigiani, G. & Johnson, W. E. ComBat-seq: batch effect adjustment for RNA-seq count data. NAR Genom. Bioinform 2, lqaa078 (2020).","journal-title":"NAR Genom. Bioinform"},{"key":"2113_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1023\/A:1023949509487","volume":"52","author":"S Monti","year":"2003","unstructured":"Monti, S., Tamayo, P., Mesirov, J. & Golub, T. Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Mach. Learn. 52, 91\u2013118 (2003).","journal-title":"Mach. Learn."},{"key":"2113_CR60","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902 e1821 (2019).","journal-title":"Cell"},{"key":"2113_CR61","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329\u2013337 e324 (2019).","journal-title":"Cell Syst."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02113-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02113-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02113-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T12:06:04Z","timestamp":1674561964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02113-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["2113"],"URL":"https:\/\/doi.org\/10.1038\/s41591-022-02113-6","relation":{"is-basis-for":[{"id-type":"doi","id":"10.52843\/cassyni.mg17p0","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"23 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.L. serves as a consultant for PACT Pharma, Inc.; has stock in, is on the board of and serves as a consultant for ennov1 LLC.; and is on the board of and holds equity in Nord Bio, Inc. C.J.W., G.G., B.A.K. and Z.L. are inventors on a patent: \u2018Compositions, Panels, and Methods for Characterizing Chronic Lymphocytic Leukemia\u2019 (PCT\/US21\/45144). C.J.W., G.G., E.M.P., I.L. and R.G. are named as inventors on U.S. provisional patent application serial number 63\/244,625, filed on 15 September 2021, and U.S. provisional patent application serial number 63\/291,213, filed on 17 December 2021, both of which are entitled \u2018Diagnosis and Prognosis of Richter\u2019s Syndrome.\u2019 G.G. is a founder of and consultant for and holds privately held equity in Scorpion Therapeutics; receives funding support from IBM and Pharmacyclics; and is an inventor on patent applications related to MSMuTect, MSMutSig, MSIDetect, POLYSOLVER and SignatureAnalyzer-GPU. R.G. receives funding support from Abbvie, AstraZeneca, Gilead, Janssen and Roche. M.S.D. served as a consultant for Abbvie, Adaptive Biotechnologies, Ascentage Pharma, AstraZeneca, BeiGene, Bristol-Myers Squibb, Eli Lilly, Genentech\/Roche, Janssen, Merck, Ono Pharmaceuticals, Pharmacyclics, Research to Practice, Takeda, TG Therapeutics, Verastem and Zentalis; receives funding support from Ascentage Pharma, AstraZeneca, Genentech\/Roche, MEI Pharma, Novartis, Pharmacyclics, Surface Oncology, TG Therapeutics and Verastem; and receives funding for travel from Abbvie, BeiGene, BioAscend, Clinical Care Options, Curio Science, Imedex, ION Solutions, Janssen, MDOutlook, PeerView, PRIME Oncology, Research to Practice and TG Therapeutics. J.R.B. has served as a consultant for Abbvie, Acerta\/AstraZeneca, BeiGene, Bristol-Myers Squibb\/Juno\/Celgene, Catapult, Eli Lilly, Genentech\/Roche, Hutchmed, Janssen, MEI Pharma, MorphoSys AG, Novartis, Pfizer, Pharmacyclics and Rigel; and received research funding from Gilead, Loxo\/Lilly, SecuraBio, Sun and TG Therapeutics. C.J.W. receives funding support from Pharmacyclics and holds equity in BioNTech, Inc. N.E.K. serves as an advisor for Abbvie, AstraZeneca, Beigene, Behring, Cytomx Therapy, Dava Oncology, Janssen, Juno Therapeutics, Oncotracker, Pharmacyclics and Targeted Oncology; receives funding support from Abbvie, Acerta Pharma, Bristol Meyer Squib, Celgene, Genentech, MEI Pharma, Pharmacyclics, Sunesis, TG Therapeutics and Tolero Pharmaceuticals; and participates on the Data Safety Monitoring Committee for Agios Pharm, AstraZeneca, BMS-Celgene, Cytomx Therapeutics, Dren Bio, Janssen, MorphoSys and Rigel. T.J.K. is on the advisory board and receives funding support from Abbvie and Roche and serves on the speakers\u2019 bureau for Abbvie, Janssen and Roche. E.T. serves as an advisor and is on the speakers\u2019 bureau for Abbvie, Janssen and Roche; and receives funding support from Abbvie and Roche. S.S. is on the advisory board and receives funding, travel support and speakers\u2019 fees from AbbVie, AstraZeneca, BeiGene, BMS, Celgene, Gilead, GSK, Hoffmann-La Roche, Janssen, Novartis and Sunesis. N.J. receives research funding from AbbVie, Adaptive Biotechnologies, ADC Therapeutics, Aprea Therapeutics, AstraZeneca, BMS, Cellectis, Fate Therapeutics, Genentech, Incyte, Loxo Oncology, Medisix, Mingsight, Novalgen, Pfizer, Pharmacyclics, Precision BioSciences, Servier and Takeda; and serves on the advisory board\/receives honoraria from AbbVie, Adaptive Biotechnologies, ADC Therapeutics, AstraZeneca, Beigene, BMS, Cellectis, Genentech, Janssen, MEI Pharma, Pharmacyclics, Precision BioSciences, Servier and TG Therapeutics. W.G.W. reports funding from Abbvie, AstraZeneca\/Acerta Pharma, Cyclacel, Genentech, Gilead Sciences, GSK\/Novartis, Janssen, Juno Therapeutics, KITE Pharma, Loxo Oncology, Inc., Miragen, Oncternal Therapeutics, Inc., Pharmacyclics LLC, Sunesis and Xencor. S.A.P. has received research funding to the institution from AbbVie, Ascentage Pharma, AstraZeneca, Janssen, Merck, Pharmacyclics and TG Therapeutics for clinical studies in which S.A.P. is a principal investigator. S.A.P has received honoraria for participation in consulting activities\/advisory board meetings for AbbVie, Adaptive Biotechnologies, Amgen, AstraZeneca, Genentech, GlaxoSmithKline, Merck and Pharmacyclics (no personal compensation). K.J.L. holds equity in Standard BioTools, Inc. D.N. has stock ownership in Madrigal Pharmaceuticals. C.S. serves on a speakers\u2019 bureau for AbbVie and AstraZeneca. D.L. holds stock in and consults for ennov1. N.P is currently an employee at Bristol Meyers Squibb. All remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}